Precision laser platform designed for investigational refractive modification of implanted intraocular lenses. The system integrates optical alignment, motion monitoring, and controlled laser delivery to enable non-invasive post-implant refractive adjustment.
Research workflow developed to evaluate refractive index shaping of implanted lenses in a clinical setting. The system supports patient docking, alignment verification, and controlled laser delivery within investigational study protocols.
Note: In vivo technology is investigational and evaluated in research and clinical study settings.
The in vivo research pathway represents a novel and investigational application of the RIS process, enabling refractive modification after intraocular lens implantation. Unlike manufacturing systems, no existing clinical platform provided the precision, stability, or optical control required for this application.
Development of the in vivo system required rethinking every element of the workflow, including patient docking, alignment, focus determination, treatment planning, and laser delivery. Each subsystem was designed to meet precision requirements that exceed those of existing ophthalmic laser platforms.
The research effort did not rely on adapting an existing clinical laser system, but instead required the development of new concepts and validation strategies tailored to the unique optical and mechanical constraints of treating an implanted lens inside the eye.
Ongoing research focuses on understanding sources of variability, defining safe operating windows, and refining workflow robustness. The in vivo application is investigational and is being evaluated through structured research and clinical study programs.
The patient is docked to the system, alignment and focus are confirmed, and the laser treatment is delivered in a controlled, office based workflow.
Repeatability, precision, and stability under controlled laboratory conditions.
Material integrity, leachables, and ISO aligned evaluations.
Investigational preclinical and clinical studies.
